Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression

被引:37
作者
Chiang, WC
Wong, YK
Lin, SC
Chang, KW
Liu, CJ
机构
[1] Taipei Mackay Mem Hosp, Dept Oral & Maxillofacial Surg, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan
[3] Taichung Vet Gen Hosp, Dept Dent, Taichung, Taiwan
[4] Mackay Jr Coll Nursing, Taipei, Taiwan
关键词
MMP-13; mouth; neoplasm; oral carcinoma; precancerous lesion;
D O I
10.1111/j.1601-0825.2005.01151.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BACKGROUND: Matrix metalloproteinases (MMPs) play pivotal roles in tumor progression. MMP-13 (collagenase-3) digests collagen and other extracellular components. MATERIALS AND METHODS: Reverse transcriptase-polymerase chain reaction (RT-PCR), immunohistochemistry and zymograph were used to study the roles of MMP-13 during the neoplastic process of oral squamous cell carcinoma (OSCC). RESULTS: Increase of MMP-13 mRNA and protein expression in OSCC cell lines relative to cultivated normal oral keratinocytes was found. MMP-13 mRNA expression in OSCC was significantly higher than in non-cancerous match tissue (NCMT) in 36 tissue pairs. Esophageal squamous cell carcinoma also exhibited high MMP-13 mRNA expression. The percentage of OSCC exhibiting strong MMP-13 immunoreactivity was significantly higher than pre-invasive lesion and NCMT. Treatment with > 5 mu m epigallocatechin-3-gallate (EGCG) to OEC-M1 cells suppressed the expression and activity of MMP-13. CONCLUSION: MMP-13 could be a potential tumor marker for OSCC. The effects of EGCG in tumor inhibition may act partially through the modulation of MMP-13.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 23 条
[1]   The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis [J].
Chang, C ;
Werb, Z .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S37-S43
[2]   Multiple molecular alterations of FHIT in betel-associated oral carcinoma [J].
Chang, KW ;
Kao, SY ;
Tzeng, RJ ;
Liu, CJ ;
Cheng, AJ ;
Yang, SC ;
Wong, YK ;
Lin, SC .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :300-306
[3]  
Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO
[4]  
2-C
[5]  
Dünne AA, 2003, ANTICANCER RES, V23, P2233
[6]  
Garbisa S, 2001, CANCER-AM CANCER SOC, V91, P822, DOI 10.1002/1097-0142(20010215)91:4<822::AID-CNCR1070>3.0.CO
[7]  
2-G
[8]  
Johansson N, 1997, CELL GROWTH DIFFER, V8, P243
[9]  
Johansson N, 1997, AM J PATHOL, V151, P499
[10]  
KHOKHA R, 1989, INVAS METAST, V9, P391